Skip to main content

Advertisement

Log in

Metastatic head and neck cutaneous basal cell carcinomas: a retrospective observational study

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Cutaneous basal cell carcinoma is usually an indolent and slow-growing tumor with potential for local invasion and recurrence; however, metastatic events are exceedingly rare. The annual incidence of metastasis is estimated to range between 0.00281 and 0.05%. A retrospective search in the pathology database of a single tertiary institution was performed in the period between 1999 to 2019. Primary cutaneous metastatic basal cell carcinomas had paraffin blocks and glass slides retrieved. A total of 8673 cases was identified. The overall prevalence of metastatic tumors was 0.05% (4/8673). The median patient’s age at diagnosis was 61 years old (range 52–79). The most common primary site of tumor was nose (2/4) and the most common histological subtype was infiltrative. The sampled lymph nodes were identified during primary tumor resection, except for 1 patient who had a sentinel lymph node biopsy performed as a surgeon individual decision. One patient had hematogenous spread to the pleura, diagnosed 5 years after diagnosis. In summary, this study adds new data to the current literature in metastatic primary cutaneous basal cell carcinomas and highlights the importance of early diagnosis and appropriate surgical excision in an effort to prevent local advanced disease, recurrence and lymphovascular dissemination.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Wahl RU, Cacchi C, Rübben A (2018) Cutaneous basal cell carcinoma with lymph node and pulmonary metastases. Case Rep Oncol Med. 2018:1–4

    Google Scholar 

  2. Mohan SV, Chang ALS (2014) Advanced basal cell carcinoma: epidemiology and therapeutic innovations. Curr Dermatol Rep. 3:40–45

    Article  Google Scholar 

  3. Hamid O, Goldenberg G (2013) Identifying patients at risk for recurrent or advanced BCC. J Drugs Dermatol JDD 12(11):1246–1252 quiz 1253–4

    PubMed  Google Scholar 

  4. Nakamura Y, Ishitsuka Y, Ohara K, Otsuka F (2012) Basal cell carcinoma on the dorsum of the foot with inguinal and pelvic lymph nodes metastases. Int J Dermatol 51(9):1068–1073

    Article  Google Scholar 

  5. Apalla Z, Lallas A, Sotiriou E, Lazaridou E, Ioannides D (2017) Epidemiological trends in skin cancer. Dermatol Pract Concept 7(2):1–6

    Article  Google Scholar 

  6. Wysong A, Aasi SZ, Tang JY (2013) Update on metastatic basal cell carcinoma: a summary of published cases from 1981 through 2011. JAMA Dermatol 149(5):615–616

    Article  Google Scholar 

  7. Bakshi A, Chaudhary SC, Rana M, Elmets CA, Athar M (2017) Basal cell carcinoma pathogenesis and therapy involving hedgehog signaling and beyond. Mol Carcinog 56(12):2543–2557

    Article  CAS  Google Scholar 

  8. Fram BR, Strony J, Jagannathan G, Brown SA (2019) Cutaneous basal cell carcinoma with bone metastases: an orthopaedic case report. Case Rep Orthop 2019:1628980

    PubMed  PubMed Central  Google Scholar 

  9. Kurian RR, Di Palma S, Barrett AW (2014) Basal cell carcinoma metastatic to parotid gland. Head and Neck Pathol 8:349–353. https://doi.org/10.1007/s12105-013-0507-3

    Article  Google Scholar 

  10. Snow SN, Sahl W, Lo JS, Mohs FE, Warner T, Dekkinga JA et al (1994) Metastatic basal cell carcinoma. Report five cases. Cancer 73(2):328–335

    Article  CAS  Google Scholar 

  11. Von Domarus H, Stevens PJ (1984) Metastatic basal cell carcinoma Report of five cases and review of 170 cases in the literature. J Am Acad Dermatol 10(6):1043–1060

    Article  Google Scholar 

  12. Kwon C-S, Awar OA, Ripa V, Said G, Rocka S (2018) Basal cell carcinoma of the scalp with destruction and invasion into the calvarium and dura mater: report of 7 cases and review of literature. J Clin Neurosci Off J Neurosurg Soc Austr 47:190–197

    Google Scholar 

  13. Kanzaki A, Ansai S-I, Ueno T, Kawana S, Shimizu A, Naito Z et al (2017) A case of metastatic basal cell carcinoma treated with cisplatin and adriamycin. J Nippon Med Sch Nippon Ika Daigaku Zasshi 84(6):286–290

    Article  Google Scholar 

  14. Gropper AB, Girouard SD, Hojman LP, Huang SJ, Qian X, Murphy GF et al (2012) Metastatic basal cell carcinoma of the posterior neck: case report and review of the literature. J Cutan Pathol 39(5):526–534

    Article  Google Scholar 

  15. Moser S, Borm J, Mihic-Probst D, Jacobsen C, Kruse Gujer AL (2014) Metastatic basal cell carcinoma: report of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol 117(2):e79–e82

    Article  Google Scholar 

  16. Morgan FC, Ruiz ES, Karia PS, Besaw RJ, Neel VA, Schmults CD (2019) Factors predictive of recurrence, metastasis, and death from primary basal cell carcinoma 2 cm or larger in diameter. J Am Acad Dermatol. https://doi.org/10.1016/j.jaad.2019.09.075

    Article  PubMed  PubMed Central  Google Scholar 

  17. Branson SV, McClintic E, Ozgur O, Esmaeli B, Yeatts RP (2017) Orbitofacial metastatic basal cell carcinoma: report of 10 cases. Ophthal Plast Reconstr Surg 33(3):213–217

    Article  Google Scholar 

  18. Siegle RJ, MacMillan J, Pollack SV (1986) Infiltrative basal cell carcinoma: a nonsclerosing subtype. J Dermatol Surg Oncol 12(8):830–836

    Article  CAS  Google Scholar 

  19. Amram AL, Hertzing WJ, Smith SV, Chévez-Barrios P, Lee AG (2018) Perineural spread of basosquamous carcinoma to the orbit, cavernous sinus, and infratemporal fossa. Orbit Amst Neth 37(2):110–114

    Google Scholar 

  20. Dandurand M, Petit T, Martel P, Guillot B, ANAES (2006) Management of basal cell carcinoma in adults Clinical practice guidelines. Eur J Dermatol EJD 16(4):394–401

    PubMed  Google Scholar 

  21. Garcia C, Poletti E, Crowson AN (2009) Basosquamous carcinoma. J Am Acad Dermatol 60(1):137–143

    Article  Google Scholar 

  22. Tang S, Thompson S, Smee R (2017) Metastatic basal cell carcinoma: case series and review of the literature. Austr J Dermatol 58(2):e40–e43

    Article  Google Scholar 

  23. Foley P (2015) Current landscape for treatment of advanced basal cell carcinoma. Austr J Dermatol 56(Suppl 1):1–7

    Article  Google Scholar 

  24. Casswell G, Cavanagh K, RaviKumar AS, Giddings C, McDowell L (2019) Setting the stage: contemporary staging of non-melanomatous skin cancer and implementation of the new American Joint Committee on cancer eighth edition staging manual. Oral Oncol 98:102–108

    Article  Google Scholar 

  25. Wahid M, Jawed A, Mandal RK, Dar SA, Khan S, Akhter N et al (2016) Vismodegib, itraconazole and sonidegib as hedgehog pathway inhibitors and their relative competencies in the treatment of basal cell carcinomas. Crit Rev Oncol Hematol 98:235–241

    Article  Google Scholar 

  26. Yin VT, Pfeiffer ML, Esmaeli B (2013) Targeted therapy for orbital and periocular basal cell carcinoma and squamous cell carcinoma. Ophthal Plast Reconstr Surg 29(2):87–92

    Article  Google Scholar 

  27. Peris K, Licitra L, Ascierto PA, Corvò R, Simonacci M, Picciotto F et al (2015) Identifying locally advanced basal cell carcinoma eligible for treatment with vismodegib: an expert panel consensus. Future Oncol Lond Engl 11(4):703–712

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Karina Furlan.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Furlan, K., Reddy, V., Alabkaa, A. et al. Metastatic head and neck cutaneous basal cell carcinomas: a retrospective observational study. Arch Dermatol Res 313, 439–443 (2021). https://doi.org/10.1007/s00403-020-02120-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-020-02120-y

Keywords

Navigation